Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy
T. Hubiche,
T. Hubiche
CHU Bordeaux, Unité de Dermatologie-Pédiatrique, National Reference Center for Rare Skin Disorders, Hôpital Pellegrin-Enfants, Place Amélie Raba-Léon, F-33076, Bordeaux Cedex, France
Search for more papers by this author C. Léauté-Labrèze,
C. Léauté-Labrèze
CHU Bordeaux, Unité de Dermatologie-Pédiatrique, National Reference Center for Rare Skin Disorders, Hôpital Pellegrin-Enfants, Place Amélie Raba-Léon, F-33076, Bordeaux Cedex, France
Search for more papers by this author A. Taïeb,
A. Taïeb
CHU Bordeaux, Unité de Dermatologie-Pédiatrique, National Reference Center for Rare Skin Disorders, Hôpital Pellegrin-Enfants, Place Amélie Raba-Léon, F-33076, Bordeaux Cedex, France
Search for more papers by this author F. Boralevi,
F. Boralevi
CHU Bordeaux, Unité de Dermatologie-Pédiatrique, National Reference Center for Rare Skin Disorders, Hôpital Pellegrin-Enfants, Place Amélie Raba-Léon, F-33076, Bordeaux Cedex, France
Search for more papers by this author
T. Hubiche,
T. Hubiche
CHU Bordeaux, Unité de Dermatologie-Pédiatrique, National Reference Center for Rare Skin Disorders, Hôpital Pellegrin-Enfants, Place Amélie Raba-Léon, F-33076, Bordeaux Cedex, France
Search for more papers by this author C. Léauté-Labrèze,
C. Léauté-Labrèze
CHU Bordeaux, Unité de Dermatologie-Pédiatrique, National Reference Center for Rare Skin Disorders, Hôpital Pellegrin-Enfants, Place Amélie Raba-Léon, F-33076, Bordeaux Cedex, France
Search for more papers by this author A. Taïeb,
A. Taïeb
CHU Bordeaux, Unité de Dermatologie-Pédiatrique, National Reference Center for Rare Skin Disorders, Hôpital Pellegrin-Enfants, Place Amélie Raba-Léon, F-33076, Bordeaux Cedex, France
Search for more papers by this author F. Boralevi,
F. Boralevi
CHU Bordeaux, Unité de Dermatologie-Pédiatrique, National Reference Center for Rare Skin Disorders, Hôpital Pellegrin-Enfants, Place Amélie Raba-Léon, F-33076, Bordeaux Cedex, France
Search for more papers by this author
First published: 18 February 2008
Correspondence: Thomas Hubiche.E-mail: [email protected]
No abstract is available for this article.
References
- 1
De Waard-van der Spek FB,
Oranje AP,
De Raeymaecker DM,
Peereboom-Wynia JD.
Juvenile versus maturity-onset alopecia areata—a comparative retrospective clinical study.
Clin Exp Dermatol
1989; 14: 429–33.
- 2
Tosti A,
Bellavista S,
Iorizzo M.
Alopecia areata: a long term follow-up study of 191 patients.
J Am Acad Dermatol
2006; 55: 438–41.
- 3
Perriard-Wolfensberger J,
Pasche-Koo F,
Mainetti C
et al.
Pulse of methylprednisolone in alopecia areata.
Dermatology
1993; 187: 282–85.
- 4
Kiesch N,
Stene JJ,
Goens J
et al.
Pulse steroid therapy for children’s severe alopecia areata?
Dermatology
1997; 194: 395–97.
- 5
Tosti A,
Guidetti MS,
Bardazzi F,
Misciali C.
Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis.
J Am Acad Dermatol
1996; 35: 199–201.
- 6
Gilhar A,
Paus R,
Kalish RS.
Lymphocytes, neuropeptides, and genes involved in alopecia areata.
J Clin Invest
2007; 117: 2019–27.
- 7
Joly P.
The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis.
J Am Acad Dermatol
2006; 55: 632–6.
